Proxy Statement (Form 8-K)

Item 5.08 Shareholder Director Nominations.

The Board of Directors (the "Board") of Lifeward Ltd. (the "Company") has set October 30, 2026 as the date for the Company's 2026 Annual and Extraordinary General Meeting of Shareholders (the "Annual Meeting"). Because the Annual Meeting will be held more than 30 days from the anniversary date of the Company's 2025 annual general meeting of shareholders, shareholders of the Company who wish to have a proposal considered for inclusion in the Company's proxy materials for the Annual Meeting pursuant to Rule 14a-8 of the Securities Exchange Act of 1934, as amended, must ensure that such proposal is received by the Company's Interim Chief Executive Officer at the Company's office located at Lifeward Ltd., 3 Hatnufa Street, 6th Floor, Yokneam Ilit, Israel, on or before September 23, 2026, including any notice on Schedule 14N, which the Company has determined is a reasonable time before it expects to begin to print and send its proxy materials. All shareholder proposals and nominations must comply with the rules and regulations promulgated by the Securities and Exchange Commission, the Israel Companies Law 5759-1999, and the Company's Articles of Association, as applicable.